logo
AI Scribes Cutting GPs' Admin and Boosting Patient Care

AI Scribes Cutting GPs' Admin and Boosting Patient Care

Medscape3 hours ago

Artificial intelligence (AI) scribing tools are increasingly being used in NHS settings to enhance patient care and free up staff time.
In April, the Department of Health and Social Care announced support for NHS doctors to adopt AI tools that 'bulldoze bureaucracy,' allowing clinicians to focus more on their patients and less on documentation.
This follows a multi-site evaluation led by Great Ormond Street Hospital for Children, London, England, and funded by NHS England. The trial tested ambient voice technologies (AVTs) that listen to and transcribe consultations in real time. More than 7000 patients took part across settings including accident and emergency, primary care, community services, and mental health.
Interim data from the trial showed increased productivity and more time spent on direct care, particularly in emergency settings.
Current AI Scribing Tools in Use
Several AI scribing tools are already being used within the NHS. Health technology company Accurx recently teamed up with Tandem Health to launch Accurx Scribe, a tool that can transcribe, summarise, and code patient consultations into a trust's clinical records, with functionality to write back to EMIS and SystmOne. It is currently being rolled out across GP practices using Accurx.
At the Royal Wolverhampton NHS Trust, a pilot of CLEARNotes is underway. The tool listens to patient consultations and generates a structured summary of the discussion.
Meanwhile, Heidi Health is being used by about 40% of GPs and is being piloted in 15 NHS trusts. The AVT tool provides real-time transcription, without storing audio files, in order to address patients' privacy concerns.
GP Practices See Significant Benefits
At Modality, a group of general practices in West Yorkshire, Heidi has been installed for all GPs and advanced clinical practitioners.
Tom Ratcliffe, a GP partner and digital transformation clinical lead for the group, said: 'Clinicians find that it saves time and reduces their administrative burden, particularly around generating clinical correspondence after consultations.'
Tom Ratcliffe
Ratcliffe described using an AI scribing tool as 'quite transformative' and particularly beneficial for clinicians who are slower typists or who take longer to write detailed notes.
'One of the really significant benefits we've experienced is that by having an ambient scribe writing the notes while you're speaking with a patient, it enables you to focus more on them,' he told Medscape News UK . 'That's really important, as you're then picking up on non-verbal cues that you can easily miss when you're distracted by the computer.'
With GPs having between 30 and 50 clinical contacts per day, 'having to think about exactly what to write for each of those encounters is quite a drain on your mental capacity,' Ratcliffe said. 'My colleagues and I have all found using an ambient scribe helps to reduce your cognitive load. Having a consistent format for the notes for every encounter is also helpful,' he added.
Patient Consent and Data Security
Educating patients about the software is an important consideration. Thomas Kelly, co-founder and chief executive of Heidi Health, said clinicians are advised to obtain consent before using the tool and to explain to patients how an AI scribe works and what they can expect during a consultation.
Thomas Kelly
'Patients can also learn more through a range of resources that GPs can put up in their practices that explain how Heidi works,' Kelly said.
A transcription of the consultation will be generated, 'but the audio is not permanently recorded or stored in a way that could ever be breached,' he explained. 'It's just being turned into that documentation in real time, and this process is happening on Heidi's servers in the UK.' However, when a session is deleted from Heidi's servers, 'it's deleted for everyone, and there is no way it can be retrieved.'
Ratcliffe said that patients have reacted positively to their Modality GP using an AI scribing tool.
'With all the digital innovations we've introduced, we've always had patients who raised very reasonable questions about the privacy of their data,' he said. 'But the level of patient acceptance of using Heidi has been incredibly high.'
Each patient is asked to give their consent for the scribing tool to be used. 'I haven't heard of a single example of a patient declining use in an encounter, and we've done probably hundreds or thousands of these now,' said Ratcliffe.
Accuracy Concerns Addressed
Andrew Noble works within the frailty service at Jean Bishop Integrated Care Centre in East Hull, England. He uses Heidi for consultations lasting up to an hour, which require lengthy administration time.
Andrew Noble
Staff training on the system emphasises vigilance about possible AI hallucinations in output.
According to Noble, one or two minor errors might occur during an hour-long consultation transcription. However, for shorter appointments, lasting 15 minutes, clinicians might expect error-free note-taking from the AI scribe.
Use of the tool has significantly improved the quality of note-taking. 'The Heidi AI scribe halved the number of spelling mistakes, and it reduced the number of abbreviations quite significantly as well,' said Noble.
Mistakes might include US spellings of antibiotics or the scribe mishearing the name of a medication. 'But we do have human error when inputting our own notes, so those things were already happening from time to time,' Noble observed.
Ratcliffe tested multiple AI scribe options before selecting Heidi Health. All platforms occasionally made minor errors.
'Anyone who uses any form of generative AI does find it will occasionally confabulate or hallucinate,' he said. 'One of the key parts of our training was around educating clinicians on the importance of understanding that their role has gone from spending lots of time typing up notes to carefully reading a transcript and checking for any potential issues.'
Overall, 'we haven't found that the error rate is high enough that means it's unsafe or not practical to use,' said Ratcliffe.
Game-Changing Technology?
Health Secretary Wes Streeting has described AI as a catalyst that will revolutionise healthcare. GPs appear to share this optimism.
'This was something that we worked really hard to roll out quickly because we did feel that it was game-changing,' Ratcliffe explained. 'I think it has been game-changing for a lot of our clinicians. When used properly, it can make a big difference.'
With GPs working 'above and beyond,' Ratcliffe believes that AI scribing tools 'could help us to move back to a safer place in terms of making our workload more manageable.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Slack Down: Monday Morning Blues For Productivity App
Slack Down: Monday Morning Blues For Productivity App

Forbes

time33 minutes ago

  • Forbes

Slack Down: Monday Morning Blues For Productivity App

Users are struggling to use Slack this morning Slack is investigating problems that are preventing some people from loading content in the corporate communications app this morning. DownDetector is reporting a sharp spike in Slack problems as Europe logs on for work on Monday morning. DownDetector shows a sharp increase in Slack outages Slack's own Status page has also acknowledged issues with the service. 'Some users may be experiencing issues loading content in Slack, particularly threads and the Activity view,' it reported at 07:25 BST. 'We're on the case and we'll be back with an update in 30 minutes.' A subsequent update added: "The work on this issue has been ongoing, but we've increased its urgency. "No additional news to share just yet, but we're focused on getting things back to normal as quickly as we can. We apologize for the continued trouble. 'We'll provide updates every 30 minutes until the impact is resolved for all users.' The problem certainly doesn't appear to be affecting all users. The service was operating normally in my brief tests this morning, suggesting it might only be affecting customers in certain regions. This is a breaking news story, more to follow.

Alphawave agrees £1.8bn takeover by America's Qualcomm
Alphawave agrees £1.8bn takeover by America's Qualcomm

Yahoo

time34 minutes ago

  • Yahoo

Alphawave agrees £1.8bn takeover by America's Qualcomm

Chip designer Alphawave has agreed to a 2.4 billion dollar (£1.8 billion) takeover by US semiconductor group Qualcomm in the latest blow to the London market. Qualcomm is offering to pay 183p per share in cash for London-listed Alphawave, which is a near-96% premium to its closing price before the takeover interest was revealed. But Qualcomm has also put forward an alternative share offer to Alphawave investors, which would see them receive Qualcomm stock instead of cash. The £1.8 billion price is less than half the £3.1 billion value at which Toronto-headquartered Alphawave floated when it listed just over four years ago. It also sees the London market lose yet another listing after a recent flurry of firms defecting from the City for rival exchanges overseas and a number of firms being bought out. Tony Pialis, president and chief executive of Alphawave, said: 'Qualcomm's acquisition of Alphawave represents a significant milestone for us and an opportunity for our business to join forces with a respected industry leader and drive value to our customers. 'Together, we will unlock new opportunities for growth, drive innovation, and create a leading player in artificial intelligence (AI) compute and connectivity solutions.' For Qualcomm, the acquisition is seen boosting its capabilities in AI infrastructure by expanding its intellectual property portfolio in data centre and 5G networking. As well as data centres, Alphawave technology is used in 5G infrastructure and autonomous vehicles. Cristiano Amon, president and chief executive of Qualcomm, said: 'The combined teams share the goal of building advanced technology solutions and enabling next-level connected computing performance across a wide array of high-growth areas, including data centre infrastructure.' The deal is expected to complete in the first three months of 2026. Alphawave, which listed in London in May 2021, has around 830 employees across operations in Canada, the UK, Europe and Korea. Sign in to access your portfolio

Qualcomm Agrees to Buy Chip Firm Alphawave for $2.4 Billion
Qualcomm Agrees to Buy Chip Firm Alphawave for $2.4 Billion

Yahoo

time39 minutes ago

  • Yahoo

Qualcomm Agrees to Buy Chip Firm Alphawave for $2.4 Billion

(Bloomberg) -- Qualcomm Inc. has agreed to buy London-listed semiconductor company Alphawave IP Group Plc for about $2.4 billion in cash to expand its technology for artificial intelligence. Next Stop: Rancho Cucamonga! Where Public Transit Systems Are Bouncing Back Around the World Trump Said He Fired the National Portrait Gallery Director. She's Still There. ICE Moves to DNA-Test Families Targeted for Deportation with New Contract US Housing Agency Vulnerable to Fraud After DOGE Cuts, Documents Warn The offer equates to about 183 pence per share for Alphawave, the companies said in a statement on Monday. That's a 96% premium to the company's share price on March 31, the last trading day before Alphawave and Qualcomm disclosed the talks. The deal, which is still subject to regulatory and shareholder approval, is expected to close in the first quarter of 2026. Qualcomm Chief Executive Officer Cristiano Amon is looking to lessen the company's reliance on the smartphone market, where growth has slowed, and push into new areas. Alphawave makes high-speed semiconductor and connectivity technology that can be used for data centers and AI applications, two growth areas in the chip industry that are being driven by demand for products like OpenAI's ChatGPT. Alphawave's board has unanimously recommended the cash offer. Investors representing 75% of shares must vote in favor of the deal for it to go through. Alphawave shareholders and directors representing about 50% of shares have agreed to vote in favor of the deal, the company said. Alphawave shares rose 23% to 183.60 pence at 8:53 a.m. in London. The shares have risen about 117% this year. Alphawave, which held an initial public offering in 2021 at 410 pence per share, has consistently traded below that level. The company had struggled with a reliance on large customers and navigating geopolitical tensions between the US and China, where Alphawave decided to cut back its business last year. Still, the company's technology has been gaining traction and had reported a surge in orders in the fourth quarter. Chief Executive Officer Tony Pialis said in a statement at the time that orders from North American AI customers were driving the business. As an alternative to the cash offer, Alphawave shareholders can also opt to exchange their stock for 0.01662 shares of Qualcomm. Qualcomm has also said that each Alphawave share could be exchanged for 0.00964 of a new 'series A Qualcomm exchangeable security' and 0.00698 of a new 'series B Qualcomm exchangeable security.' The Alphawave directors declined to recommend the alternative offers. In particular, they said they're unable to declare whether the second alternative deal, where shareholders trade stock for exchangeable securities, is fair and reasonable 'given the significant and variable impact of the advantages and disadvantages.' (Updates with premium in second paragraph) The SEC Pinned Its Hack on a Few Hapless Day Traders. The Full Story Is Far More Troubling Cavs Owner Dan Gilbert Wants to Donate His Billions—and Walk Again Is Elon Musk's Political Capital Spent? What Does Musk-Trump Split Mean for a 'Big, Beautiful Bill'? Cuts to US Aid Imperil the World's Largest HIV Treatment Program ©2025 Bloomberg L.P. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store